GlyCOVID

GlyCOVID is a dataset of RDFized COVID-19 data related to glycans. Resources will be added incrementally as publications are curated.

Longitudinal Development of Antibody Responses in COVID-19 Patients of Different Severity with ELISA, Peptide, and Glycan Arrays: An Immunological Case Series.
Heidepriem J, et al.
Pathogens. 2021; 10(4):438. https://doi.org/10.3390/pathogens10040438

A longitudinal analysis of three COVID-19 patients with moderate (#1) and mild disease (#2 and #3) was published. Antibody serum responses were analyzed using spike glycoprotein enzyme linked immunosorbent assay (ELISA), full-proteome peptide, and glycan microarrays. In this Glycovid dataset, the data from these glycan microarray experiments have been RDFized. Fluorescence intensity is given in arbitrary fluorescence units (AFU) as reported in this publication.

Source Last Updated
PSICQUIC March 30, 2022
Displaying entries 301 - 325 of 4050 in total
Antibody Patient Onset (days) Symptom GlyTouCan ID Arbitrary Fluorescence Units (AFU) ▼
IgM Patient 1 6 moderate
G71142DF
2147
IgA Patient 2 24 mild
G35446HX
2139
IgG Patient 2 24 mild
G25559RS
2133
IgA Patient 3 -180 mild
G76615YG
2131
IgM Patient 4 12 mild
G75896PD
2119
IgG Patient 2 15 mild
G35446HX
2118
IgA Patient 3 11 mild
G82204SH
2095
IgM Patient 2 15 mild
G00066MO
2083
IgM Patient 4 12 mild
G35446HX
2083
IgA Patient 3 11 mild
G43648DB
2073
IgA Patient 2 24 mild
G42666HT
2058
IgM Patient 1 10 moderate
G49108TO
2057
IgM Patient 3 4 mild
G00057MO
2028
IgG Patient 2 24 mild
G35446HX
2027
IgG Patient 3 4 mild
G12200GB
2024
IgA Patient 4 12 mild
G80587NA
2018
IgG Patient 2 3 mild
G27689OB
2008
IgG Patient 2 24 mild
G62826CL
2007
IgA Patient 3 11 mild
G12200GB
2001
IgA Patient 3 4 mild
G12200GB
1965
IgG Patient 2 15 mild
G26295XE
1950
IgM Patient 1 22 moderate
G49108TO
1945
IgM Patient 4 12 mild
G71142DF
1944
IgM Patient 3 11 mild
G00057MO
1910
IgM Patient 3 -180 mild
G80587NA
1898

About Release Notes Help Feedback

Click here to visit the beta site.


International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.1.0

Last updated: December 9, 2024